ZYBT
Zhengye Biotechnology Holding Limited
There isn't enough reported data to score ZYBT yet.
ZYBT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Healthy |
ZYBT's balance sheet is currently healthy, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
ZYBT PE Valuation
ZYBT has no meaningful PE right now: it lost money over the past year.
ZYBT Forward outlook
There aren't enough analyst estimates for ZYBT to show an outlook.
ZYBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.22 | -650% |
ZYBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.6M | -18% |
| Q4 2025 | $8.1M | -71% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -41% | N/A |
| Q4 2025 | -77% | N/A |
| Q2 2025 | -46% | N/A |
| Q4 2024 | 8.8% | N/A |
ZYBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3M | -$895.5K |
| Q4 2025 | $4M | -3.3% |
| Q4 2024 | $4.1M | +62% |
| Q4 2023 | $2.5M | +643% |
| Q3 2023 | $2.5M | +2389% |
| Q2 2023 | $511.6K | +$2.3M |
| Q1 2023 | $511.6K | +$1.4M |
ZYBT usually generates cash, though not every quarter: the latest was −$3M, but it generated $3M over the past year.
ZYBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 1.7x | Healthy |
ZYBT's net debt is about 1.7 years of its operating earnings (EBITDA).
ZYBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 14.1 | Oversold |
ZYBT's weekly RSI is 51 (neutral) and its Stochastic is 14 (oversold).
ZYBT PE vs Healthcare Sector
| Metric | ZYBT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ZYBT has no meaningful PE right now: it lost money over the past year.
ZYBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.44 | 4.2% above |
| 20 week MA | $1.42 | 5.6% above |
| 50 week MA | $1.19 | 26% above |
ZYBT is in an uptrend: it's above all three of its weekly moving averages, and 26% above its 50-week average.
ZYBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $4.62 | $1.53 | -67% |
| 2026 YTD | $1.53 | $1.50 | -2% |
ZYBT has finished every year since 2025 lower, and it's down 2% so far in 2026.